Entero Therapeutics, Inc. announced on February 14, 2025, that its board of directors has appointed Mr. Richard Paolone as the interim Chief Executive Officer of the company.
Mr. Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. He has advised numerous companies on strategic business initiatives and represented them in both private and public offerings of debt and equity securities.
His background includes serving as a director or officer for several private and publicly traded companies, providing strategic insights and governance expertise. This appointment follows his recent addition to the company's Board of Directors in February 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.